Ionis Pharmaceuticals
Ionis describes a portfolio of RNA- and DNA-targeted medicines, with separate pipeline, medicines, clinical-trial, and scientific-publication resources. Product-specific mechanisms and development status should be checked against dated disclosures.
Corporate information
- Company entity
- Ionis Pharmaceuticals
- Headquarters / principal office
- Carlsbad, California, United States ↗
- Founded
- 1989 ↗
- Ownership / capital status
- Publicly tradedPublicly traded (NASDAQ: IONS; IPO in 1991) ↗
- Official corporate reference
- https://ionis.com/ ↗
- LinkedIn company page
- LinkedIn ↗ ↗
Profile review: 2026-11-04 · Fields retain their individual source dates. Undisclosed values are not zero; early or historical events do not establish the latest financing. Awards and acquisitions are distinguished from equity rounds.
Start with public sources and capability boundaries; company claims are not independent certification.
Ask AI ↗Public evidence snapshot
Ionis describes a portfolio of RNA- and DNA-targeted medicines, with separate pipeline, medicines, clinical-trial, and scientific-publication resources. Product-specific mechanisms and development status should be checked against dated disclosures.
This profile is a research snapshot, not a company endorsement. Check original sources for current information.